Extracellular Vesicles in Tauopathies: Mechanisms and Applications
Open Access
- 19 February 2026
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 27 (4) , 1998
Abstract
Extracellular vesicles (EVs) are nanoscale membrane-enclosed vesicles that mediate intercellular communication and participate in both physiological and pathological signaling processes. Recent studies underscore the critical roles of EVs in the propagation of tau pathology and the diagnostic and therapeutic aspects of tauopathies, a class of neurodegenerative diseases marked by the pathological accumulation of the protein tau, contributing to cognitive decline and neuronal loss. This review aims to explore the many roles of EVs in tauopathies, emphasizing their ability to carry and transmit misfolded tau, modulate immune responses through microglial interactions, and serve as carriers of disease-specific biomarkers. We describe current findings on extravesicular tau, miRNAs, and mRNAs as diagnostic indicators in Alzheimer’s disease and related tauopathies and evaluate the therapeutic potential of both endogenous and engineered EVs for delivering therapeutic agents or neuroprotective cargo. Challenges such as isolation standardization, cargo loading efficiency, and biodistribution are also discussed, along with potential strategies to overcome them. Overall, the evidence emphasizes EVs as key players in the pathophysiology, diagnosis, and treatment of tauopathies, offering a strong and compelling platform for precision medicine and clinical applications in the future.Keywords
Funding Information
- Florida Department of Health Ed and Ethel Moore Alzheimer’s Disease Research Program (23A07)
- Preeminent Postdoctoral Program
- Office of Undergraduate Research
- Learning Institute for Elders at the University of Central Florida (LIFE at UCF) Al Dallago
This publication has 144 references indexed in Scilit:
- Preclinical Alzheimer's disease shows alterations in circulating neuronal‐derived extracellular vesicle microRNAs in a multiethnic cohortAlzheimer's & Dementia, 2025
- Human‐Derived Induced GABAergic Progenitor Cells Improve Cognitive Function in Mice and Inhibit Astrocyte Activation with Anti‐Inflammatory ExosomesAnnals of Neurology, 2024
- The six brain‐specific TAU isoforms and their role in Alzheimer's disease and related neurodegenerative dementia syndromesAlzheimer's & Dementia, 2024
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Exosomes Derived from M2 Microglial Cells Modulated by 1070‐nm Light Improve Cognition in an Alzheimer's Disease Mouse ModelAdvanced Science, 2023
- The Microglial membrane receptor TREM2 mediates exosome secretion to promote phagocytosis of amyloid‐β by microgliaFEBS Letters, 2022
- Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stageAlzheimer's & Dementia, 2020
- Association of Extracellular Vesicle Biomarkers With Alzheimer Disease in the Baltimore Longitudinal Study of AgingJAMA Neurology, 2019
- Exosome–Liposome Hybrid Nanoparticles Deliver CRISPR/Cas9 System in MSCsAdvanced Science, 2018
- Downregulated serum miR‐223 servers as biomarker in Alzheimer's diseaseCell Biochemistry and Function, 2016